Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral minocycline for geographic atrophy associated with age-related macular degeneration
2017-000946-24Phase 2Unknown
- Sponsor
- National Eye Institute
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minocycline in geographic atrophy (GA) and age-related macular degeneration (AMD), sponsored by National Eye Institute. Status: unknown.
02
Drugs
minocycline
03
Conditions
geographic atrophy (GA)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2017-000946-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000946-24.